IMMUNOGLOBULIN HUMAN ANTITETANUS, 250 IU/ml, syr.
STD
DVACIMTE2S-
Valid Article
Account code:
60010
HS Code:
300212
Last Updated on:
02/09/2024, 22:24:55
Former
Code(s):
DVACATET2S-
11.2.1 - Human immunoglobulins
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
J06BB02
Anatomical Therapeutic Chemical Classification according to WHOCC
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
The product is part of at least one Kit.
A kit is a collection of products (medical and/or logistic) that are needed for a certain intervention in emergency. The choice and quantity of the articles reflects the MSF protocols for this specific situation. The use of Kits allows to start an intervention without a detailed evaluation.
IMMUNOGLOBULIN HUMAN ANTITETANUS
- In the WHO list of Essential Medicines 2023 (500 IU in vial only)
Therapeutic Action
Human tetanus immunoglobulin contains mainly immunoglobulin G (IgG) with a specifically high content of antibodies against the toxin produced by the bacteria Clostridium tetani.
Indications
Instructions for use
Must be given by IM route only.
Do not administer by IV route.
Precautions for Use
As with all injectable vaccines and/or immunoglobulins, appropriate medical treatment should always be readily available in case of rare anaphylactic reactions following the administration of the product.
Storage
- Keep refrigerated between 2ºC and 8ºC - Protect from sunlight
- Do not freeze.